Protein hydrolysate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for protein hydrolysate and what is the scope of patent protection?
Protein hydrolysate
is the generic ingredient in two branded drugs marketed by Abbvie and B Braun, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for protein hydrolysate.
Summary for protein hydrolysate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 3 |
Clinical Trials: | 1 |
DailyMed Link: | protein hydrolysate at DailyMed |
Recent Clinical Trials for protein hydrolysate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Baylor College of Medicine | Phase 2 |
U.S. Department of Education | Phase 2 |
US Patents and Regulatory Information for protein hydrolysate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | HYPROTIGEN 5% | protein hydrolysate | INJECTABLE;INJECTION | 006170-003 | Jan 10, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbvie | AMINOSOL 5% | protein hydrolysate | INJECTABLE;INJECTION | 005932-012 | Jan 31, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |